Impedimed Limited Stock Market Value

IPDQF Stock  USD 0.05  0.00  0.00%   
ImpediMed's market value is the price at which a share of ImpediMed trades on a public exchange. It measures the collective expectations of ImpediMed Limited investors about its performance. ImpediMed is trading at 0.0483 as of the 2nd of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0483.
With this module, you can estimate the performance of a buy and hold strategy of ImpediMed Limited and determine expected loss or profit from investing in ImpediMed over a given investment horizon. Check out ImpediMed Correlation, ImpediMed Volatility and ImpediMed Alpha and Beta module to complement your research on ImpediMed.
Symbol

Please note, there is a significant difference between ImpediMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImpediMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImpediMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ImpediMed 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImpediMed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImpediMed.
0.00
11/02/2024
No Change 0.00  0.0 
In 31 days
12/02/2024
0.00
If you would invest  0.00  in ImpediMed on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding ImpediMed Limited or generate 0.0% return on investment in ImpediMed over 30 days. ImpediMed is related to or competes with Artivion, Anika Therapeutics, Sight Sciences, Orthofix Medical, Avanos Medical, Glaukos Corp, and Orthopediatrics Corp. ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy de... More

ImpediMed Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImpediMed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImpediMed Limited upside and downside potential and time the market with a certain degree of confidence.

ImpediMed Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ImpediMed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImpediMed's standard deviation. In reality, there are many statistical measures that can use ImpediMed historical prices to predict the future ImpediMed's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0523.60
Details
Intrinsic
Valuation
LowRealHigh
0.000.0423.59
Details
Naive
Forecast
LowNextHigh
00.0723.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.050.07
Details

ImpediMed Limited Backtested Returns

ImpediMed is out of control given 3 months investment horizon. ImpediMed Limited holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. We were able to break down and collect data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 2.99% are justified by taking the suggested risk. Use ImpediMed Limited Downside Deviation of 35.03, market risk adjusted performance of (0.95), and Risk Adjusted Performance of 0.077 to evaluate company specific risk that cannot be diversified away. ImpediMed holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.21, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ImpediMed are expected to decrease by larger amounts. On the other hand, during market turmoil, ImpediMed is expected to outperform it. Use ImpediMed Limited treynor ratio, as well as the relationship between the downside variance and kurtosis , to analyze future returns on ImpediMed Limited.

Auto-correlation

    
  -0.72  

Almost perfect reverse predictability

ImpediMed Limited has almost perfect reverse predictability. Overlapping area represents the amount of predictability between ImpediMed time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImpediMed Limited price movement. The serial correlation of -0.72 indicates that around 72.0% of current ImpediMed price fluctuation can be explain by its past prices.
Correlation Coefficient-0.72
Spearman Rank Test-0.7
Residual Average0.0
Price Variance0.0

ImpediMed Limited lagged returns against current returns

Autocorrelation, which is ImpediMed pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImpediMed's pink sheet expected returns. We can calculate the autocorrelation of ImpediMed returns to help us make a trade decision. For example, suppose you find that ImpediMed has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ImpediMed regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImpediMed pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImpediMed pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImpediMed pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

ImpediMed Lagged Returns

When evaluating ImpediMed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImpediMed pink sheet have on its future price. ImpediMed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImpediMed autocorrelation shows the relationship between ImpediMed pink sheet current value and its past values and can show if there is a momentum factor associated with investing in ImpediMed Limited.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in ImpediMed Pink Sheet

ImpediMed financial ratios help investors to determine whether ImpediMed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImpediMed with respect to the benefits of owning ImpediMed security.